Ltd., Singapore
As filed · General Updates
M&AWatchMajormateriality 82 out of 100
What happened
FactLtd., Singapore. Limited (“SPG”), a step-down wholly-owned. In this regard, it is proposed to acquire 100% stake in Amexel Pte.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedEarlierQ1 FY27
EBITDA to PAT conversion at ~50%+
NowQ1 FY27
We expect gross margins to remain in the 58-60% range.
Change
FactTarget revision
Implication
CapitSignal interpretationThe stated figure moved 20.00%.confidence 60%
Watch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- Aspire to focus on North America Business Revenue of ~$375m by FY28 despite current external headwinds (management committed by FY28)
- Continue to add new customers in Europe by leveraging strong commercial presence and robust supply chain (management committed by FY27)
Evidence
- Acquisition of 100% stake in Amexel Pte. Ltd., Singapore by Strides Pharma Global Pte. Limited, a step-down wholly-owned Subsidiary of the Company.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%